Company Filing History:
Years Active: 2020
Title: Silvia Carvalho: Innovator in Cancer Treatment
Introduction
Silvia Carvalho is a prominent inventor based in Rehovot, Israel. She has made significant contributions to the field of cancer treatment through her innovative research and patented technologies. Her work focuses on developing methods and compositions that enhance the effectiveness of cancer therapies.
Latest Patents
Silvia Carvalho holds a patent for "Anti amphiregulin antibodies, compositions comprising same and uses thereof." This patent describes a method for determining the suitability of a subject for treatment with an anti-amphiregulin antibody. The method is particularly relevant for patients with cancers such as ovarian cancer, head and neck cancer, and pancreatic cancer that exhibit resistance to chemotherapy. The process involves analyzing biological samples to assess the expression levels of amphiregulin, transforming growth factor alpha (TGF-alpha), and heparin-binding epidermal growth factor (HB-EGF). A specific expression pattern indicates the suitability of the subject for treatment with the anti-amphiregulin antibody.
Career Highlights
Silvia Carvalho has dedicated her career to advancing cancer research and treatment methodologies. Her innovative approaches have led to the development of new therapeutic strategies that aim to improve patient outcomes. With her expertise, she has become a key figure in the field of oncology.
Collaborations
Silvia has collaborated with notable researchers, including Yosef Yarden and Moshit Lindzen. These partnerships have further enriched her research and contributed to the advancement of cancer treatment technologies.
Conclusion
Silvia Carvalho's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patented methods and compositions hold promise for improving the lives of patients facing challenging cancer diagnoses.